AR115049A1 - Carboxialquil quitosano - Google Patents

Carboxialquil quitosano

Info

Publication number
AR115049A1
AR115049A1 ARP180103294A ARP180103294A AR115049A1 AR 115049 A1 AR115049 A1 AR 115049A1 AR P180103294 A ARP180103294 A AR P180103294A AR P180103294 A ARP180103294 A AR P180103294A AR 115049 A1 AR115049 A1 AR 115049A1
Authority
AR
Argentina
Prior art keywords
carboxyalkyl
chitosan
glucosamine units
mol
defined according
Prior art date
Application number
ARP180103294A
Other languages
English (en)
Inventor
Guillermo Rocasalbas
Houta Choumane
Philippe Vaesen
Sandrine Emilia Gautier
Pierre Douette
Mickal Chausson
Original Assignee
Kiomed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61802047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR115049(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kiomed Pharma filed Critical Kiomed Pharma
Publication of AR115049A1 publication Critical patent/AR115049A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicación 1: Carboxialquilo de quitosano de origen fúngico caracterizado porque presenta unidades glucosamina, unidades N-acetil-glucosamina, y unidades glucosamina sustituidas por un grupo carboxialquilo, y dicho carboxialquilo de quitosano presenta, de preferencia, un grado de sustitución por un grupo carboxialquilo superior al 20%, expresado en número de mol del sustituyente, con respecto al número de mol de unidades totales. Reivindicación 16: Procedimiento de preparación de una composición caracterizado porque comprende un carboxialquilo de quitosano definido de acuerdo con una cualquiera de las reivindicaciones 8 a 14, y dicho procedimiento comprende: la disolución de un carboxialquilo de quitosano definido de acuerdo con una cualquiera de las reivindicaciones 1 a 9 en una solución acuosa, de preferencia agua, eventualmente tamponada, de preferencia a pH comprendido entre 6,2 y 8,5, y de preferencia entre 6,5 y 7,5; el ajuste eventual del pH a un pH deseado, en general al pH fisiológico para la aplicación prevista, por ejemplo, por adición de un agente tamponante, de una base o de un ácido; la adición eventual de otros excipientes como, por ejemplo, un azúcar reductor, por ejemplo, sorbitol o manitol; el ajuste eventual de la osmolalidad final de la composición.
ARP180103294A 2017-11-28 2018-11-12 Carboxialquil quitosano AR115049A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1761323A FR3074044B1 (fr) 2017-11-28 2017-11-28 Carboxyalkyl chitosane

Publications (1)

Publication Number Publication Date
AR115049A1 true AR115049A1 (es) 2020-11-25

Family

ID=61802047

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180103294A AR115049A1 (es) 2017-11-28 2018-11-12 Carboxialquil quitosano

Country Status (20)

Country Link
US (2) US11667727B2 (es)
EP (1) EP3510051B2 (es)
AR (1) AR115049A1 (es)
CA (1) CA3082557A1 (es)
CL (1) CL2020001323A1 (es)
DK (1) DK3510051T3 (es)
EA (1) EA202091062A1 (es)
ES (1) ES2781787T5 (es)
FI (1) FI3510051T4 (es)
FR (1) FR3074044B1 (es)
HR (1) HRP20200411T4 (es)
MA (1) MA49811A1 (es)
MX (1) MX2020005002A (es)
PE (1) PE20210441A1 (es)
PL (1) PL3510051T5 (es)
PT (1) PT3510051T (es)
SG (1) SG11202005039WA (es)
TN (1) TN2020000070A1 (es)
UA (1) UA126087C2 (es)
WO (1) WO2019105719A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112111022B (zh) * 2020-10-10 2021-06-04 山东一滕新材料股份有限公司 一种改性壳聚糖及其制备方法、瓷砖胶添加剂及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619995A (en) * 1984-12-24 1986-10-28 Nova Chem Limited N,O-carboxymethyl chitosan and preparative method therefor
US5679658A (en) * 1995-05-08 1997-10-21 Chitogenics, Inc. N,O-carbonxymethylchitosan for prevention of surgical adhesions
DE19725037B4 (de) 1997-06-13 2004-08-05 Cognis Deutschland Gmbh & Co. Kg Chitinderivate, Verfahren zu deren Herstellung und deren Verwendung
US6645947B1 (en) * 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
BE1014638A6 (fr) 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
CN1193044C (zh) 2003-01-09 2005-03-16 武汉大学 羧甲基壳聚糖的制备方法
EP1691779A4 (en) 2003-11-24 2009-01-21 Optimer Pharmaceuticals Inc TREATMENT OF A STATE IN A MAMMALIAN WITH THE ADMINISTRATION OF COMPOUNDS AND APPLICATION METHOD THEREFOR
BE1016383A3 (fr) 2004-12-15 2006-10-03 Physiol Composition polymere pour lentille intraoculaire.
CN102688195B (zh) 2012-06-06 2014-01-08 中国海洋大学 一种具有pH敏感性的包载盐酸阿霉素的壳聚糖羧甲基壳聚糖纳米缓释微粒的制备方法
CN103937014B (zh) 2014-04-10 2016-05-25 北京爱美客生物科技有限公司 壳聚糖双网络快速响应型可注射水凝胶及其制备方法
FR3024362A1 (fr) 2014-08-01 2016-02-05 Synolyne Pharma Sa Composition thermogelifiable sterilisee
FR3024363B1 (fr) * 2014-08-01 2018-08-10 Synolyne Pharma Composition thermogelifiable
FR3029116B1 (fr) 2014-12-01 2018-03-30 Advanced Chitosan Solutions Biotech Procede d'obtention d'un gel de cartilage pour la reparation cartilagineuse, comprenant du chitosane et des chondrocytes
FR3038837B1 (fr) 2015-07-13 2017-08-18 Synolyne Pharma Chitosane pour melange avec un fluide coagulable
FR3038838B1 (fr) 2015-07-13 2017-08-18 Synolyne Pharma Chitosane pour melange avec un fluide coagulable
CN106474569B (zh) 2016-12-02 2019-04-09 上海其胜生物制剂有限公司 一种羧甲基几丁质临界水凝胶的制备方法
CN107325306B (zh) 2017-06-13 2019-10-25 爱美客技术发展股份有限公司 壳聚糖或其衍生物多重交联凝胶和制备方法
FR3116534B1 (fr) 2020-11-23 2023-12-22 Kiomed Pharma Billes à base de chitosane, préparation, compositions et applications

Also Published As

Publication number Publication date
MX2020005002A (es) 2020-08-27
PL3510051T3 (pl) 2020-11-02
EP3510051B1 (fr) 2020-01-01
PT3510051T (pt) 2020-04-06
HRP20200411T1 (hr) 2020-06-12
MA49811A1 (fr) 2020-10-28
TN2020000070A1 (fr) 2022-01-06
US11667727B2 (en) 2023-06-06
SG11202005039WA (en) 2020-06-29
WO2019105719A1 (fr) 2019-06-06
PL3510051T5 (pl) 2023-01-30
PE20210441A1 (es) 2021-03-08
US20210171667A1 (en) 2021-06-10
EP3510051A1 (fr) 2019-07-17
CA3082557A1 (fr) 2019-06-06
FI3510051T4 (en) 2022-12-15
EP3510051B2 (fr) 2022-10-05
EA202091062A1 (ru) 2020-08-07
HRP20200411T4 (hr) 2022-11-25
ES2781787T3 (es) 2020-09-07
FR3074044B1 (fr) 2019-11-01
CL2020001323A1 (es) 2020-09-11
US20230174682A1 (en) 2023-06-08
ES2781787T5 (es) 2023-02-27
FR3074044A1 (fr) 2019-05-31
DK3510051T3 (da) 2020-03-16
UA126087C2 (uk) 2022-08-10

Similar Documents

Publication Publication Date Title
WO2019075263A3 (en) Methods and compositions for topical delivery
ECSP16084431A (es) Composiciones estables de yodo no en complejo y métodos de uso
BRPI0711380A2 (pt) hidrogéis de misturas de polissacarídeos para engenharia de tecido e como veículos de compostos ativos
JP2010540619A5 (es)
AR096438A1 (es) Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
ES2539305R2 (es) Recubrimiento comestible para la conservación de trozos de fruta, su proceso de fabricación y de aplicación
PH12015501623A1 (en) Glyco-modified atrial natriuretic peptide
CL2013002973A1 (es) Compuestos derivados de esteres de fenilglucopiranosil sustituidos mediadores del co-transportador sodio/d-glucosa (sglt); composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento del sindrome metabolico, sindrome x, diabetes, resistencia a la insulina, entre otros
PE20121660A1 (es) Conservantes de derivados de quitina
MX2016007316A (es) Prevencion de infecciones por staphylococcus aureus mediante vacunas de glucoproteina sintetizadas en escherichia coli.
PH12017501341A1 (en) Oligosaccharide compositions for use as food ingredients and methods of producing thereof
BR112017022821A2 (pt) solução aquosa homogênea de quitosana injetável apresentando um ph próximo do ph fisiológico
MX2017001226A (es) Composicion termogelificante esterilizada.
AR115049A1 (es) Carboxialquil quitosano
HRP20180178T1 (hr) Pripravci ketorolaka, namijenjeni zacjeljivanju rane na rožnici
RU2017118261A (ru) Содержащая хитозан композиция, стерилизованная путем нагрева, а также способ ее получения
RU2015115143A (ru) Ранозаживляющий гель для наружного применения
WO2015071299A3 (en) Stable pharmaceutical glycylcycline compositions
RU2013133548A (ru) Кровоостанавливающий препарат
CA2903759C (en) Concentrated aqueous azalide formulations
RU2014148029A (ru) Средство для подавления роста волос
JP2016512819A5 (es)
Lee et al. Antibacterial Activity of Chitosan against Antibiotics Resistance Bacteria in Porcine Semen
WO2016027160A3 (en) Nasal composition comprising mixture of hyaluronic acids and saline solution
RU2013133476A (ru) Иммунометаболический состав с антимикробной активностью

Legal Events

Date Code Title Description
FG Grant, registration